Technical University of Munich

Targeting neoantigens in multiple myeloma with CAR T-cell 5:56
Targeting neoantigens in multiple myeloma with CAR T-cell
Angela Krackhard • 6 Apr 2022
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma 2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard • 6 Apr 2022
Developing individualized cancer therapies with neoantigen-specific TCRs 4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard • 6 Apr 2022
Improving immune-imaging tools to assess cancer immunotherapies 5:33
Improving immune-imaging tools to assess cancer immunotherapies
Angela Krackhard • 6 Apr 2022
Accelerating the identification of clinically relevant T cell therapies 2:17
Accelerating the identification of clinically relevant T cell therapies
Elvira D’Ippolito • 31 Mar 2022
Unanswered questions in developing engineered T cells for solid tumors 2:35
Unanswered questions in developing engineered T cells for solid tumors
Elvira D’Ippolito • 31 Mar 2022
Novel approaches in lymphocyte engineering 3:31
Novel approaches in lymphocyte engineering
Elvira D’Ippolito • 31 Mar 2022
The content of VJRegenMed is intended for healthcare professionals